329 related articles for article (PubMed ID: 10340917)
41. Effect of polymorphism of the beta(2)-adrenergic receptor on response to regular use of albuterol in asthma.
Israel E; Drazen JM; Liggett SB; Boushey HA; Cherniack RM; Chinchilli VM; Cooper DM; Fahy JV; Fish JE; Ford JG; Kraft M; Kunselman S; Lazarus SC; Lemanske RF; Martin RJ; McLean DE; Peters SP; Silverman EK; Sorkness CA; Szefler SJ; Weiss ST; Yandava CN;
Int Arch Allergy Immunol; 2001; 124(1-3):183-6. PubMed ID: 11306963
[TBL] [Abstract][Full Text] [Related]
42. Beta2-adrenergic receptor polymorphisms affect response to treatment in children with severe asthma exacerbations.
Carroll CL; Stoltz P; Schramm CM; Zucker AR
Chest; 2009 May; 135(5):1186-1192. PubMed ID: 19029431
[TBL] [Abstract][Full Text] [Related]
43. β2-adrenergic receptor gene polymorphism and response to bronchodilating treatment evaluated by spirometry.
Poziomkowska-Gesicka I; Gawlikowska-Sroka A; Dzieciolowska-Baran E; Teul I; Adler G; Ciechanowicz A; Kurek M
Adv Exp Med Biol; 2013; 755():169-77. PubMed ID: 22826064
[TBL] [Abstract][Full Text] [Related]
44. [The role of beta 2-adrenoceptor gene polymorphisms in asthma].
Sato R
Hokkaido Igaku Zasshi; 2000 Mar; 75(2):81-94. PubMed ID: 10791249
[TBL] [Abstract][Full Text] [Related]
45. Genetic polymorphisms of the beta 2-adrenergic receptor in nocturnal and nonnocturnal asthma. Evidence that Gly16 correlates with the nocturnal phenotype.
Turki J; Pak J; Green SA; Martin RJ; Liggett SB
J Clin Invest; 1995 Apr; 95(4):1635-41. PubMed ID: 7706471
[TBL] [Abstract][Full Text] [Related]
46. Pharmacogenetics of β2 adrenergic receptor gene polymorphisms, long-acting β-agonists and asthma.
Chung LP; Waterer G; Thompson PJ
Clin Exp Allergy; 2011 Mar; 41(3):312-26. PubMed ID: 21294785
[TBL] [Abstract][Full Text] [Related]
47. Analysis of ADRB2 (Arg16Gly) Gene Variant with Susceptibility, Pharmacogenetic Response and Disease Severity in South Indian Asthmatics.
Bandaru S; Akka J; Marri VK; Alvala M; Ponnala D; Mundluru HP
Inflammation; 2015 Dec; 38(6):2146-55. PubMed ID: 26071206
[TBL] [Abstract][Full Text] [Related]
48. Identification of high affinity bioactive Salbutamol conformer directed against mutated (Thr164Ile) beta 2 adrenergic receptor.
Bandaru S; Tiwari G; Akka J; Marri VK; Alvala M; Gutlapalli VR; Nayarisseri A; Mundluru HP
Curr Top Med Chem; 2015; 15(1):50-6. PubMed ID: 25579570
[TBL] [Abstract][Full Text] [Related]
49. beta-2 Adrenergic receptor variants affect resting blood pressure and agonist-induced vasodilation in young adult Caucasians.
Gratze G; Fortin J; Labugger R; Binder A; Kotanko P; Timmermann B; Luft FC; Hoehe MR; Skrabal F
Hypertension; 1999 Jun; 33(6):1425-30. PubMed ID: 10373227
[TBL] [Abstract][Full Text] [Related]
50. Roflumilast, a once-daily oral phosphodiesterase 4 inhibitor, lacks relevant pharmacokinetic interactions with inhaled salbutamol when co-administered in healthy subjects.
Bethke TD; Giessmann T; Westphal K; Weinbrenner A; Hauns B; Hauschke D; David M; Lahu G; Zech K; Hermann R; Siegmund W
Int J Clin Pharmacol Ther; 2006 Nov; 44(11):572-9. PubMed ID: 17176624
[TBL] [Abstract][Full Text] [Related]
51. Molecular properties and pharmacogenetics of a polymorphism of adenylyl cyclase type 9 in asthma: interaction between beta-agonist and corticosteroid pathways.
Tantisira KG; Small KM; Litonjua AA; Weiss ST; Liggett SB
Hum Mol Genet; 2005 Jun; 14(12):1671-7. PubMed ID: 15879435
[TBL] [Abstract][Full Text] [Related]
52. Genetic polymorphisms as biomarkers of sensitivity to inhaled sulfur dioxide in subjects with asthma.
Winterton DL; Kaufman J; Keener CV; Quigley S; Farin FM; Williams PV; Koenig JQ
Ann Allergy Asthma Immunol; 2001 Feb; 86(2):232-8. PubMed ID: 11258696
[TBL] [Abstract][Full Text] [Related]
53. Beta2-adrenoceptor regulation and function in female asthmatic patients receiving the oral combined contraceptive pill.
Tan KS; McFarlane LC; Lipworth BJ
Chest; 1998 Feb; 113(2):278-82. PubMed ID: 9498939
[TBL] [Abstract][Full Text] [Related]
54. Arginase 1 and arginase 2 variations associate with asthma, asthma severity and beta2 agonist and steroid response.
Vonk JM; Postma DS; Maarsingh H; Bruinenberg M; Koppelman GH; Meurs H
Pharmacogenet Genomics; 2010 Mar; 20(3):179-86. PubMed ID: 20124949
[TBL] [Abstract][Full Text] [Related]
55. Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Accurately Predicts the Better Bronchodilatory Effect of Inhaled Versus Oral Salbutamol Dosage Forms.
Boger E; Fridén M
J Aerosol Med Pulm Drug Deliv; 2019 Feb; 32(1):1-12. PubMed ID: 29878860
[TBL] [Abstract][Full Text] [Related]
56. Plasma concentrations and effects of salbutamol administered orally to patients with cystic fibrosis.
Demnati R; Michoud MC; Jeanneret-Grosjean A; Ong H; Du Souich P
Br J Clin Pharmacol; 1995 Oct; 40(4):319-24. PubMed ID: 8554933
[TBL] [Abstract][Full Text] [Related]
57. Polymorphisms of the β2-adrenergic receptor correlated to nocturnal asthma and the response of terbutaline nebulizer.
Lee MY; Cheng SN; Chen SJ; Huang HL; Wang CC; Fan HC
Pediatr Neonatol; 2011 Feb; 52(1):18-23. PubMed ID: 21385652
[TBL] [Abstract][Full Text] [Related]
58. Influence of beta2-adrenergic receptor genotype on airway function during exercise in healthy adults.
Snyder EM; Beck KC; Dietz NM; Joyner MJ; Turner ST; Johnson BD
Chest; 2006 Mar; 129(3):762-70. PubMed ID: 16537879
[TBL] [Abstract][Full Text] [Related]
59. The Arg16Gly polymorphism of the beta2-adrenergic receptor and the natriuretic response to rapid saline infusion in humans.
Snyder EM; Turner ST; Joyner MJ; Eisenach JH; Johnson BD
J Physiol; 2006 Aug; 574(Pt 3):947-54. PubMed ID: 16728452
[TBL] [Abstract][Full Text] [Related]
60. The pharmacokinetic profile of inhaled and oral salbutamol in elite athletes with asthma and nonasthmatic subjects.
Elers J; Pedersen L; Henninge J; Hemmersbach P; Dalhoff K; Backer V
Clin J Sport Med; 2012 Mar; 22(2):140-5. PubMed ID: 22388343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
